Literature DB >> 22341554

Skin and needle hygiene intervention for injection drug users: results from a randomized, controlled Stage I pilot trial.

Kristina T Phillips1, Michael D Stein, Bradley J Anderson, Karen F Corsi.   

Abstract

A new skin and needle hygiene intervention, designed to reduce high-risk injection practices associated with bacterial and viral infections, was tested in a pilot, randomized controlled trial. Participants included 48 active heroin injectors recruited through street outreach and randomized to either a 2-session intervention or an assessment-only condition (AO) and followed up for 6 months. The primary outcome was skin- and needle-cleaning behavioral skills measured by videotaped demonstration. Secondary outcomes were high-risk injection practices, intramuscular injection, and bacterial infections. Intervention participants had greater improvements on the skin (d = 1.00) and needle-cleaning demonstrations (d = .52) and larger reductions in high-risk injection practices (d = .32) and intramuscular injection (d = .29), with a lower incidence rate of bacterial infections (hazard ratio = .80), at 6 months compared with AO. The new intervention appears feasible and promising as a brief intervention to reduce bacterial and viral risks associated with drug injection.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22341554      PMCID: PMC3358564          DOI: 10.1016/j.jsat.2012.01.003

Source DB:  PubMed          Journal:  J Subst Abuse Treat        ISSN: 0740-5472


  48 in total

1.  High prevalence of abscesses and cellulitis among community-recruited injection drug users in San Francisco.

Authors:  I A Binswanger; A H Kral; R N Bluthenthal; D J Rybold; B R Edlin
Journal:  Clin Infect Dis       Date:  2000-03       Impact factor: 9.079

Review 2.  Management of multidrug-resistant organisms in health care settings, 2006.

Authors:  Jane D Siegel; Emily Rhinehart; Marguerite Jackson; Linda Chiarello
Journal:  Am J Infect Control       Date:  2007-12       Impact factor: 2.918

3.  Effectiveness of HIV/AIDS interventions on drug use and needle risk behaviors for out-of-treatment injection drug users.

Authors:  R E Booth; C F Kwiatkowski; R C Stephens
Journal:  J Psychoactive Drugs       Date:  1998 Jul-Sep

4.  Behavioral HIV risk reduction among people who inject drugs: meta-analytic evidence of efficacy.

Authors:  Michael M Copenhaver; Blair T Johnson; I-Ching Lee; Jennifer J Harman; Michael P Carey
Journal:  J Subst Abuse Treat       Date:  2006-07-13

5.  Microbiologic study of street heroin and injection paraphernalia.

Authors:  C U Tuazon; R Hill; J N Sheagren
Journal:  J Infect Dis       Date:  1974-03       Impact factor: 5.226

6.  Community-associated methicillin-resistant Staphylococcus aureus is prevalent in wounds of community-based injection drug users.

Authors:  E Lloyd-Smith; M W Hull; M W Tyndall; R Zhang; E Wood; J S G Montaner; T Kerr; M G Romney
Journal:  Epidemiol Infect       Date:  2010-03-05       Impact factor: 2.451

7.  Sharing of drug preparation equipment as a risk factor for hepatitis C.

Authors:  H Hagan; H Thiede; N S Weiss; S G Hopkins; J S Duchin; E R Alexander
Journal:  Am J Public Health       Date:  2001-01       Impact factor: 9.308

8.  Non-fatal overdose and subsequent drug treatment among injection drug users.

Authors:  Robin A Pollini; Lisa McCall; Shruti H Mehta; David Vlahov; Steffanie A Strathdee
Journal:  Drug Alcohol Depend       Date:  2005-11-23       Impact factor: 4.492

9.  Targeting HIV-related outcomes with intravenous drug users maintained on methadone: a randomized clinical trial of a harm reduction group therapy.

Authors:  S Kelly Avants; Arthur Margolin; Mary Helen Usubiaga; Cheryl Doebrick
Journal:  J Subst Abuse Treat       Date:  2004-03

10.  Methicillin-resistant Staphylococcus aureus nasal carriage among injection drug users: six years later.

Authors:  G N Al-Rawahi; A G Schreader; S D Porter; D L Roscoe; R Gustafson; E A Bryce
Journal:  J Clin Microbiol       Date:  2007-11-26       Impact factor: 5.948

View more
  8 in total

1.  Barriers to practicing risk reduction strategies among people who inject drugs.

Authors:  Kristina T Phillips
Journal:  Addict Res Theory       Date:  2015-07-21

2.  Injection Drug Users' Perceived Barriers to Using Self-Initiated Harm Reduction Strategies.

Authors:  Erin E Bonar; Harold Rosenberg
Journal:  Addict Res Theory       Date:  2014-08-01

3.  Risk Factors Associated With Skin and Soft Tissue Infections Among Hospitalized People Who Inject Drugs.

Authors:  Kristina T Phillips; Bradley J Anderson; Debra S Herman; Jane M Liebschutz; Michael D Stein
Journal:  J Addict Med       Date:  2017 Nov/Dec       Impact factor: 3.702

4.  Association of skin infections with sharing of injection drug preparation equipment among people who inject drugs.

Authors:  Raagini Jawa; Michael D Stein; Bradley Anderson; Jane M Liebschutz; Catherine Stewart; Kristina T Phillips; Joshua A Barocas
Journal:  Int J Drug Policy       Date:  2021-03-18

5.  High Perineal and Overall Frequency of Staphylococcus aureus in People Who Inject Drugs, Compared to Non-Injectors.

Authors:  Disa Dahlman; Farnaz Jalalvand; Marianne Alanko Blomé; Anders Håkansson; Håkan Janson; Susanne Quick; Anna C Nilsson
Journal:  Curr Microbiol       Date:  2016-11-28       Impact factor: 2.188

Review 6.  Soft Tissue, Bone, and Joint Infections in People Who Inject Drugs.

Authors:  Carlos S Saldana; Darshali A Vyas; Alysse G Wurcel
Journal:  Infect Dis Clin North Am       Date:  2020-09       Impact factor: 5.982

7.  A randomized controlled trial of a brief behavioral intervention to reduce skin and soft tissue infections among people who inject drugs.

Authors:  Kristina T Phillips; Catherine Stewart; Bradley J Anderson; Jane M Liebschutz; Debra S Herman; Michael D Stein
Journal:  Drug Alcohol Depend       Date:  2021-02-27       Impact factor: 4.492

8.  Transmission dynamics for Methicilin-resistant Staphalococous areus with injection drug user.

Authors:  Rebekah Wagner; Folashade B Agusto
Journal:  BMC Infect Dis       Date:  2018-02-07       Impact factor: 3.090

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.